Based on the Noevir Holdings Co Ltd stock forecast from 0 analysts, the average analyst target price for Noevir Holdings Co Ltd is not available over the next 12 months. Noevir Holdings Co Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Noevir Holdings Co Ltd is Slightly Bullish , which is based on 8 positive signals and 4 negative signals. At the last closing, Noevir Holdings Co Ltd’s stock price was JPY 4,760.00. Noevir Holdings Co Ltd’s stock price has changed by -1.75% over the past week, -4.13% over the past month and -6.48% over the last year.
No recent analyst target price found for Noevir Holdings Co Ltd
No recent average analyst rating found for Noevir Holdings Co Ltd
Company Overview Noevir Holdings Co Ltd
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel and aircrafts. The company also produces and sells toiletries; market research; and provides air transportation and training services. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Chuo, Japan. Read Less
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare...Read More
Frequently Asked Questions About Noevir Holdings Co Ltd (4928:TSE) Stock
Stock Target Advisor's fundamental analysis for Noevir Holdings Co Ltd's stock is Slightly Bullish .
4928:TSE stock's dividend yield is 9.05%.
Our analysis grades 4928:TSE stock's dividend yield at A+. This means that 4928:TSE stock's dividend yield is above 97% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4928:TSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 4928:TSE's stock to indicate what its average analyst target is.
4928:TSE stock's Price/Earning ratio is 21.34.
Our analysis grades 4928:TSE stock's Price / Earning ratio at D. This means that 4928:TSE stock's Price/Earning ratio is above 37% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4928:TSE may be fairly valued for its sector
The last closing price of 4928:TSE's stock was JPY 4,760.00.
The most recent market capitalization for 4928:TSE is JPY 170.10B.
Unfortunately we do not have enough analyst data on 4928:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Noevir Holdings Co Ltd's stock.
As per our most recent records Noevir Holdings Co Ltd has 0 Employees.
Noevir Holdings Co Ltd's registered address is 6-13-1 Minatojima-Nakamachi, Chuo, Japan, 650-8521.
You can get more information about it from Noevir Holdings Co Ltd's website at https://www.noevirholdings.co.jp.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Noevir Holdings Co Ltd (4928:TSE) Stock
Stock Target Advisor's fundamental analysis for Noevir Holdings Co Ltd's stock is Slightly Bullish .
4928:TSE stock's dividend yield is 9.05%.
Our analysis grades 4928:TSE stock's dividend yield at A+. This means that 4928:TSE stock's dividend yield is above 97% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4928:TSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 4928:TSE's stock to indicate what its average analyst target is.
4928:TSE stock's Price/Earning ratio is 21.34.
Our analysis grades 4928:TSE stock's Price / Earning ratio at D. This means that 4928:TSE stock's Price/Earning ratio is above 37% of the stocks in the Household & Personal Products sector in the TSE exchange.
Based on this 4928:TSE may be fairly valued for its sector
The last closing price of 4928:TSE's stock was JPY 4,760.00.
The most recent market capitalization for 4928:TSE is JPY 170.10B.
Unfortunately we do not have enough analyst data on 4928:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Noevir Holdings Co Ltd's stock.
As per our most recent records Noevir Holdings Co Ltd has 0 Employees.
Noevir Holdings Co Ltd's registered address is 6-13-1 Minatojima-Nakamachi, Chuo, Japan, 650-8521.
You can get more information about it from Noevir Holdings Co Ltd's website at https://www.noevirholdings.co.jp.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4928:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
